Wellness & longevity FAQs What are vitamin IV drips and how do they work
Why this trial matters: First large Phase III evidence of biopsy-confirmed histologic benefit with a metabolic drug in MASH Demonstrates semaglutides impact beyond weight loss to disease-modifying liver effects Supports expanding GLP-1 therapeutics into liver disease care amid a high unmet need Ianalumab Meets Endpoints in Phase III Sjgrens Disease Trials (NEPTUNUS-1 & 2) Novartis reported that both Phase III studies of ianalumab achieved their primary endpoints in patients with Sjgrens disease, offering the first targeted therapy with statistically significant disease activity reduction in this chronic autoimmune disorder
Who Shouldand Should NotTake Semaglutide for Weight Loss
When lifestyle and dietary modifications provide insufficient relief, several medical interventions may help manage GLP-1-related bloating
Just six research-backed botanicals to support your body's natural GLP-1 response
[Google Scholar] 123.Rodon J, Postel-Vinay S, Hollebecque A, Nuciforo P, Azaro A, Cattan V, et al